Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. At argenx, we are committed to putting the patient first. The Director, US Patient Assistance Program (PAP), will play a critical role in ensuring patients who face financial barriers are able to access therapy through a compliant, scalable, and patient-centered support model. Role Overview The Director, US Patient Assistance Program (PAP), will lead the strategy, design, and execution of argenx’s PAP across current and future indications. This individual will partner closely with US Patient Advocacy leadership and cross-functional stakeholders to evolve a best-in-class operating model that supports access today while building a scalable foundation for pipeline expansion. This role requires both strategic thinking and operational depth. The Director will shape future-state program design while ensuring day-to-day excellence in execution, vendor oversight, compliance, and case management performance.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director